Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.955
-0.015 (-0.51%)
At close: Aug 1, 2025, 4:00 PM
2.950
-0.005 (-0.17%)
After-hours: Aug 1, 2025, 7:22 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Antibody-Based Therapeutics
850.00K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
850.00K